Funding for this research was provided by:
National Institutes of Health (1K23DK099237, 1P30DK92924)
Agency for Healthcare Research and Quality (1R01HS022963, R01HS019859)
Received: 3 September 2019
Revised: 3 February 2020
Accepted: 11 March 2020
First Online: 16 April 2020
Compliance with Ethical Standards
: This study was approved by the KPCO Institutional Review Board (IRB), with the other institutions’ IRBs ceding oversight to the KPCO IRB. Informed consent was not required.
: M.C. reports additional grant funding from the Department of Defense, Sanofi, Kadmon, AstraZeneca, and Corvidia. G.A.N. reports additional grant funding from Boehringer Ingelheim, Merck & Co, Bristol-Myers Squibb, and Amarin Pharma.
: The study sponsors had no role in the study design, collection, analysis, and interpretation of data; writing the report; and the decision to submit the report for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Agency for Healthcare Research and Quality.
Free to read: This content has been made available to all.